Studies have demonstrated that PI3K/Akt is associated with depression, and regulating this signaling pathway can exert antidepressant effects by regulating brain-derived neurotrophic factors and their receptors, regulating glutamate receptors and their transporter proteins, and inhibiting neuronal apoptosis [61, 62]. This evidence concerns the gene AKT1 and depressive disorder.